A share price of Lantern Pharma Inc [LTRN] is currently trading at $4.23, up 4.96%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The LTRN shares have gain 6.02% over the last week, with a monthly amount glided 37.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Lantern Pharma Inc [NASDAQ: LTRN] stock has seen the most recent analyst activity on October 07, 2021, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $32.
Lantern Pharma Inc experienced fluctuations in its stock price throughout the past year between $2.55 and $6.12. Lantern Pharma Inc [NASDAQ: LTRN] shares were valued at $4.23 at the most recent close of the market.
Analyzing the LTRN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.94, Equity is -0.83 and Total Capital is -1.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.83 points at the first support level, and at 3.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.53, and for the 2nd resistance point, it is at 4.83.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Lantern Pharma Inc [NASDAQ:LTRN] is 4.86. As well, the Quick Ratio is 4.86, while the Cash Ratio is 1.49.
Transactions by insiders
Recent insider trading involved Fletcher Aaron G.L., 10% Owner, that happened on Jun 13 ’25 when 40000.0 shares were sold. 10% Owner, Kreis Leslie W. completed a deal on Jun 13 ’25 to sell 40000.0 shares. Meanwhile, 10% Owner Fletcher Aaron G.L. sold 60647.0 shares on Jun 12 ’25.
